The aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme

Pei Ying Lee, Chi Long Chen, Zhong Zhe Lin, Ann Lii Cheng, Edmund I Tsuen Chen, Jacqueline Whang-Peng, Chi Ying F Huang

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology